F/M Emerald Life Sciences Innovation ETF (LFSC)

Assets	$51.20M
Expense Ratio	0.54%
PE Ratio	n/a
Shares Out	2.24M
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Ratio	n/a
1-Year Return	n/a

Volume	282
Open	23.10
Previous Close	22.98
Day's Range	23.10 - 23.10
52-Week Low	18.78
52-Week High	27.76
Beta	n/a
Holdings	33
Inception Date	Oct 31, 2024

About LFSC

Fund Home Page

The F/M Emerald Life Sciences Innovation ETF (LFSC) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed ETF that targets US health care and biotechnology companies identified to have promising life sciences opportunities. LFSC was launched on Oct 31, 2024 and is issued by F/m Investments.

• Asset Class: Equity
• Category: Health
• Region: North America
• Stock Exchange: NASDAQ
• Ticker Symbol: LFSC
• ETF Provider: F/m Investments

Top 10 Holdings

60.65% of assets

Name	Symbol	Weight
Soleno Therapeutics, Inc.	SLNO	7.37%
RadNet, Inc.	RDNT	6.90%
BridgeBio Pharma, Inc.	BBIO	6.88%
TransMedics Group, Inc.	TMDX	6.46%
Blueprint Medicines Corporation	BPMC	6.42%
LivaNova PLC	LIVN	6.35%
Travere Therapeutics, Inc.	TVTX	6.16%
Merit Medical Systems, Inc.	MMSI	5.31%
Collegium Pharmaceutical, Inc.	COLL	4.47%
Alphatec Holdings, Inc.	ATEC	4.33%